Official websites use .gov A .gov website belongs to an official government organization
in  the  United  States.  Secure  .gov  websites  use  HTTPS  A  lock  (   )  or  https://  means
you've  safely  connected  to  the  .gov  website.  Share  sensitive  information  only  on
official, secure websites. 
Patients  on  treatment  for  latent  TB  infection  (LTBI)  or  TB  disease  should  report  any
signs and symptoms of adverse drug reactions to their health care provider, including
*Patients  taking  rifampin  (RIF)  or  rifapentine  (RPT)  should  be  informed  that  they  will
notice an orange discoloration of urine and possibly other body fluids. This is normal.
Patients should provide a list of current medications to avoid drug interactions. Some
interactions  to  note:  Healthcare  providers  treating  patients  with  the  combination
regimen of isoniazid and rifapentine in 12 once-weekly doses (3HP) should 
For Patients For Health Care Providers To receive email updates about this page, enter
your email address:
Source URL: https://www.cdc.gov/tb/topic/treatment/adverseevents.htm
